Overview

Study in Elderly Patients With Early Breast Cancer (ICE)

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This trial is done to determine the role of adjuvant chemotherapy with capecitabine in patients ≥ 65.
Phase:
Phase 3
Details
Lead Sponsor:
German Breast Group
Collaborators:
AstraZeneca
Hoffmann-La Roche
Treatments:
Capecitabine
Diphosphonates
Ibandronic Acid